100 related articles for article (PubMed ID: 26567133)
1. HD5 and HBD1 variants' solvation potential energy correlates with their antibacterial activity against Escherichia coli.
Porto WF; Nolasco DO; Pires ÁS; Fernandes GR; Franco OL; Alencar SA
Biopolymers; 2016 Jan; 106(1):43-50. PubMed ID: 26567133
[TBL] [Abstract][Full Text] [Related]
2. Prediction of the impact of coding missense and nonsense single nucleotide polymorphisms on HD5 and HBD1 antibacterial activity against Escherichia coli.
Porto WF; Nolasco DO; Pires ÁS; Pereira RW; Franco OL; Alencar SA
Biopolymers; 2016 Sep; 106(5):633-44. PubMed ID: 27160989
[TBL] [Abstract][Full Text] [Related]
3. Variations in the interaction of human defensins with Escherichia coli: Possible implications in bacterial killing.
Mathew B; Nagaraj R
PLoS One; 2017; 12(4):e0175858. PubMed ID: 28423004
[TBL] [Abstract][Full Text] [Related]
4. Different dynamics and pathway of disulfide bonds reduction of two human defensins, a molecular dynamics simulation study.
Zhang L
Proteins; 2017 Apr; 85(4):665-681. PubMed ID: 28106297
[TBL] [Abstract][Full Text] [Related]
5. Self-Assembling Myristoylated Human α-Defensin 5 as a Next-Generation Nanobiotics Potentiates Therapeutic Efficacy in Bacterial Infection.
Lei R; Hou J; Chen Q; Yuan W; Cheng B; Sun Y; Jin Y; Ge L; Ben-Sasson SA; Chen J; Wang H; Lu W; Fang X
ACS Nano; 2018 Jun; 12(6):5284-5296. PubMed ID: 29856606
[TBL] [Abstract][Full Text] [Related]
6. Visualizing attack of Escherichia coli by the antimicrobial peptide human defensin 5.
Chileveru HR; Lim SA; Chairatana P; Wommack AJ; Chiang IL; Nolan EM
Biochemistry; 2015 Mar; 54(9):1767-77. PubMed ID: 25664683
[TBL] [Abstract][Full Text] [Related]
7. Design of a potent antibiotic peptide based on the active region of human defensin 5.
Wang C; Shen M; Gohain N; Tolbert WD; Chen F; Zhang N; Yang K; Wang A; Su Y; Cheng T; Zhao J; Pazgier M; Wang J
J Med Chem; 2015 Apr; 58(7):3083-93. PubMed ID: 25782105
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of human α-defensin 5 and its linear analogs: N-terminal fatty acylation results in enhanced antimicrobial activity of the linear analogs.
Mathew B; Nagaraj R
Peptides; 2015 Sep; 71():128-40. PubMed ID: 26206286
[TBL] [Abstract][Full Text] [Related]
9. Expression and structure/function relationships of human defensin 5.
Chapnik N; Levit A; Niv MY; Froy O
Appl Biochem Biotechnol; 2012 Apr; 166(7):1703-10. PubMed ID: 22354633
[TBL] [Abstract][Full Text] [Related]
10. New role for human α-defensin 5 in the fight against hypervirulent Clostridium difficile strains.
Furci L; Baldan R; Bianchini V; Trovato A; Ossi C; Cichero P; Cirillo DM
Infect Immun; 2015 Mar; 83(3):986-95. PubMed ID: 25547793
[TBL] [Abstract][Full Text] [Related]
11. Effects of the terminal charges in human neutrophil alpha-defensin 2 on its bactericidal and membrane activity.
Xie C; Zeng P; Ericksen B; Wu Z; Lu WY; Lu W
Peptides; 2005 Dec; 26(12):2377-83. PubMed ID: 16009464
[TBL] [Abstract][Full Text] [Related]
12. Functional determinants of human enteric α-defensin HD5: crucial role for hydrophobicity at dimer interface.
Rajabi M; Ericksen B; Wu X; de Leeuw E; Zhao L; Pazgier M; Lu W
J Biol Chem; 2012 Jun; 287(26):21615-27. PubMed ID: 22573326
[TBL] [Abstract][Full Text] [Related]
13. Exploring the impact of the recombinant Escherichia coli strain on defensins antimicrobial activity: BL21 versus Origami strain.
López-Cano A; Martínez-Miguel M; Guasch J; Ratera I; Arís A; Garcia-Fruitós E
Microb Cell Fact; 2022 May; 21(1):77. PubMed ID: 35527241
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the Bacterial Membrane Disruption Mechanism of Human α-Defensin 5: A Theoretical Study.
Jung SW; Lee J; Cho AE
J Phys Chem B; 2017 Feb; 121(4):741-748. PubMed ID: 28067516
[TBL] [Abstract][Full Text] [Related]
15. Systematic mutational analysis of human neutrophil α-defensin HNP4.
Hu H; Di B; Tolbert WD; Gohain N; Yuan W; Gao P; Ma B; He Q; Pazgier M; Zhao L; Lu W
Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):835-844. PubMed ID: 30658057
[TBL] [Abstract][Full Text] [Related]
16. Efficient production of a correctly folded mouse α-defensin, cryptdin-4, by refolding during inclusion body solubilization.
Tomisawa S; Sato Y; Kamiya M; Kumaki Y; Kikukawa T; Kawano K; Demura M; Nakamura K; Ayabe T; Aizawa T
Protein Expr Purif; 2015 Aug; 112():21-8. PubMed ID: 25913370
[TBL] [Abstract][Full Text] [Related]
17. Impact of pro segments on the folding and function of human neutrophil alpha-defensins.
Wu Z; Li X; Ericksen B; de Leeuw E; Zou G; Zeng P; Xie C; Li C; Lubkowski J; Lu WY; Lu W
J Mol Biol; 2007 Apr; 368(2):537-49. PubMed ID: 17355880
[TBL] [Abstract][Full Text] [Related]
18. The Function and Modification of Human Defensin 5.
Chang XY; Zhang MW; Zhang LJ; Chai LQ
Protein Pept Lett; 2023; 30(10):830-840. PubMed ID: 37861034
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of human alpha-defensins 4-6.
Wu Z; Ericksen B; Tucker K; Lubkowski J; Lu W
J Pept Res; 2004 Sep; 64(3):118-25. PubMed ID: 15317502
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity and specificity of the six human {alpha}-defensins.
Ericksen B; Wu Z; Lu W; Lehrer RI
Antimicrob Agents Chemother; 2005 Jan; 49(1):269-75. PubMed ID: 15616305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
